Resting CD4+ T cells is higher than activated CD4+ T cells and naive CD4+ T cells in COAD, TGCT, BLCA, pheochromocytoma and paraganglioma (PCPG), GBM, UVM and BRCA. This evidence concerns the gene CD4 and glioblastoma.